ZBH

ZBH

USD

Zimmer Biomet Holdings Inc. Common Stock

$103.180+3.170 (3.170%)

Real-time Price

Healthcare
Medical devices
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$100.010

High

$103.690

Low

$99.455

Volume

9.20M

Company Fundamentals

Market Cap

20.4B

Industry

Medical devices

Country

United States

Trading Stats

Avg Volume

1.41M

Exchange

NYQ

Currency

USD

52-Week Range

Low $89.22Current $103.180High $114.72

Related News

PR Newswire

Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has ...

View more
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
Analyst Upgrades

Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Maintains $101 Price Target

Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings with a Hold and maintains $101 price target.

View more
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Maintains $101 Price Target
PR Newswire

Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting bold innovations across ...

View more
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
Analyst Upgrades

BTIG Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $122

BTIG analyst Ryan Zimmerman maintains Zimmer Biomet Holdings with a Buy and raises the price target from $118 to $122.

View more
BTIG Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $122
PR Newswire

Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, a wholly owned subsidiary, today announced the...

View more
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases
Analyst Upgrades

Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Lowers Price Target to $104

Evercore ISI Group analyst Vijay Kumar maintains Zimmer Biomet Holdings with a In-Line and lowers the price target from $106 to $104.